Teoxane Awarded by Deloitte's "Switzerland's Best Managed Companies" Program for the Second Consecutive Year

Geneva, June 28, 2024

For over two decades, Teoxane has been committed to providing healthcare practitioners with the highest quality and performance products, while supporting them with cutting-edge medical education to best meet the needs and expectations of patients.

Teoxane's strategy is based on clear objectives:

• Continually innovating to anticipate market needs,
• Ensuring patient safety and practitioner satisfaction,
• Striving for excellence in all aspects of its business on a global scale.

This approach is supported by robust internal infrastructure and processes, rigorous performance monitoring, continuous communication at all hierarchical levels, and maintaining constant dialogue with market stakeholders.

"Receiving this award again from Deloitte is an immense pride for our entire company and a valuable validation of our work. This distinction is further proof of the relevance and sustainability of our model. It also reflects our teams' ability to strive for continuous improvements and to excel in terms of quality, performance, and safety. This results in constant innovation across all areas, enabling Teoxane to advance industry standards."  Valérie Taupin, CEO and Founder of Teoxane 

A notable example of this effort is the achievement of MDR (Medical Device Regulation) certification, which required six years of work from our teams. Through this collective effort, Teoxane became the first player in its industry to be MDR certified for its entire product range across all indications.

As an independent market player, Teoxane has been able to continuously invest in developing its internal capabilities to support sustained growth. This year, the launch of a new production line has doubled the production capacity at the Geneva headquarters. The "Swiss Made" label is proudly maintained, reflecting the superior quality of Teoxane products.

In 2024, Teoxane's leadership team has been strengthened to support its international expansion. This ensures ongoing alignment between strategic vision and implemented actions, fostering healthy and sustainable company growth.

In a demanding economic, political, and societal context, Teoxane's agility and organizational excellence, once again recognized by Deloitte, remain essential to successfully meeting the challenges of an ever-evolving market.